ISCT2025_c28b189e-335e-446c-a8f0-49453e6c336a
Continuous Flow Transfection With Flowfect Technology As An Efficient, Non-Viral Technology For Scalable, Crispr-Mediated Engineering Of Primary T-Cells 

Continuous Flow Transfection With Flowfect Technology As An Efficient, Non-Viral Technology For Scalable, Crispr-Mediated Engineering Of Primary T-Cells 

Machine Learning Approach To DNA Transfection Optimization Of Primary T Cells Using Flowfect® Technology

Machine Learning Approach To DNA Transfection Optimization Of Primary T Cells Using Flowfect® Technology

Continuous Flow Transfection With Flowfect® Technology Enables Rapid Optimization And Scale-Up For Efficient Co-Delivery Of mRNA And Plasmid DNA In Primary Human T Cells

Continuous Flow Transfection With Flowfect® Technology Enables Rapid Optimization And Scale-Up For Efficient Co-Delivery Of mRNA And Plasmid DNA In Primary Human T Cells 

ISCT 2025 Enhancing Non Viral CRL Poster

Enhancing Non-viral Engineering of Cells for Cell Therapy Manufacturing ​- Optimizing Yields for Peak Cell Quality with the Flowfect Tx™ Platform